论文部分内容阅读
中间淋巴细胞淋巴瘤(ILL)是非何杰金淋巴瘤一种特异性亚型,其细胞学特征介于小淋巴细胞淋巴瘤(SLL)和弥漫性小裂核淋巴瘤(DSCCL)之间,其恶性程度有报告为中度恶性,也有低度恶性。但缺乏临床比较研究。为此,作者就上述3类型的临床病程比较ILL的病理特征与恶性程度关系。作者收集1984～1988年住院105例弥漫型淋巴细胞性淋巴瘤患者,其中ILL40例;SLL51例;DSCCL14例。ILL中位生存期,SLL两者无明显差异;DSCCL明显短于ILL和SLL(P分别<0.04和
Intermediate Lymphoid Lymphoma (ILL) is a specific subtype of non-Hodgkin’s lymphoma with cytological features between small lymphocyte lymphoma (SLL) and diffuse small nucleus lymphoma (DSCCL). The degree of malignancy has been reported as moderate malignancy and low malignancy. However, there is a lack of clinical comparative studies. To this end, the author compares the pathological features of ILL with the degree of malignancy in relation to the above three types of clinical course. The authors collected 105 patients with diffuse lymphoblastic lymphoma from 1984 to 1988, of whom 40 were ILL, 51 were SLL, and 14 were DSCCL. There was no significant difference in the median survival time of ILL and SLL; DSCCL was significantly shorter than ILL and SLL (P<0.04 and